|Published||Report Code||Available Format||Pages|
Note: This report can also be updated as of date and delivered within 1-2 working days of purchase confirmation
This report includes the age-related macular degeneration therapeutics pipeline analysis as of May 2017, to estimate and analyze the emerging therapies and their progress status in different phases of development. The report also contains competitive analysis and extensive information on monotherapies, targets and mechanism of action, and drug origin with relevance to age-related macular degeneration.
Age-Related Macular Degeneration Therapeutics Pipeline Analysis